Comments
Loading...

ORIC Pharmaceuticals

ORICNASDAQ
Logo brought to you by Benzinga Data
$11.16
0.494.59%
At Close: -
$11.50
0.343.05%
After Hours: 6:02 PM EDT
15 minutes delayed
Consensus Rating1
Outperform
Highest Price Target1
$27.00
Lowest Price Target1
$14.00
Consensus Price Target1
$19.44

ORIC Pharmaceuticals (NASDAQ:ORIC) Stock, Analyst Ratings, Price Targets, Forecasts

ORIC Pharmaceuticals Inc has a consensus price target of $19.44 based on the ratings of 11 analysts. The high is $27 issued by Baird on August 16, 2023. The low is $14 issued by Citigroup on May 7, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Wedbush, and Stifel on September 18, 2024, September 10, 2024, and September 6, 2024, respectively. With an average price target of $20.33 between HC Wainwright & Co., Wedbush, and Stifel, there's an implied 76.81% upside for ORIC Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jun
2
Jul
2
Aug
2
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Wedbush
Stifel
Oppenheimer
Citigroup

1calculated from analyst ratings

Analyst Ratings for ORIC Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for ORIC Pharmaceuticals (ORIC) stock?

A

The latest price target for ORIC Pharmaceuticals (NASDAQ:ORIC) was reported by HC Wainwright & Co. on September 18, 2024. The analyst firm set a price target for $21.00 expecting ORIC to rise to within 12 months (a possible 82.61% upside). 24 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for ORIC Pharmaceuticals (ORIC)?

A

The latest analyst rating for ORIC Pharmaceuticals (NASDAQ:ORIC) was provided by HC Wainwright & Co., and ORIC Pharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for ORIC Pharmaceuticals (ORIC)?

A

The last upgrade for ORIC Pharmaceuticals Inc happened on March 23, 2023 when HC Wainwright & Co. raised their price target to $16. HC Wainwright & Co. previously had a neutral for ORIC Pharmaceuticals Inc.

Q

When was the last downgrade for ORIC Pharmaceuticals (ORIC)?

A

The last downgrade for ORIC Pharmaceuticals Inc happened on March 21, 2023 when Guggenheim changed their price target from N/A to $15 for ORIC Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for ORIC Pharmaceuticals (ORIC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ORIC Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ORIC Pharmaceuticals was filed on September 18, 2024 so you should expect the next rating to be made available sometime around September 18, 2025.

Q

Is the Analyst Rating ORIC Pharmaceuticals (ORIC) correct?

A

While ratings are subjective and will change, the latest ORIC Pharmaceuticals (ORIC) rating was a reiterated with a price target of $21.00 to $21.00. The current price ORIC Pharmaceuticals (ORIC) is trading at is $11.50, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch